Head of Investor Relations
Amneal Pharmaceuticals, Inc. (AMRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMRX alertsAnthony DiMeo is recorded as Head of Investor Relations at Amneal Pharmaceuticals, Inc. (AMRX). Anthony DiMeo has spoken on 4 earnings calls across 1 company, most recently for Amneal Pharmaceuticals, Inc. on May 3, 2024. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.
“Good morning, and thank you for joining Amneal Pharmaceuticals' First Quarter 2024 Earnings Call. Today, we issued a press release reporting Q1 results.”
“Good morning, and thank you for joining Amneal Pharmaceuticals Third Quarter 2023 Earnings Call. Today, we issued a press release reporting our Q3 results. We announced certain unaudited preliminary results for Q3 on October 23.”
“Good morning, and thank you for joining Amneal Pharmaceuticals' second quarter 2023 earnings call.”
“Ladies and gentlemen, we currently have no further questions. I would now like to hand over to Chirag Patel for final remarks.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
